A.P. Pharma Bookmark and Share

ArticleDateSource
MAP Pharma falls on 4Q loss and restatementMarch 29, 2012Health News - CNBC
AP Pharma loss grows to $1.4MMay 16, 2011Health News - BizJournals.com
Mid-cap pharma firm up on hopes healthy Q4 numbersApril 06, 2011Pharmaceutical - Moreover
Bear of the Day: Largecap pharma that lost 10% in 2 daysFebruary 23, 2011Pharmaceutical - Moreover
UPDATE: Allergan To Help Sell Map Pharma's Migraine TreatmentJanuary 31, 2011Health News - Fox Business
Allergan To Help Sell Map Pharma's Migraine TreatmentJanuary 31, 2011Health News - Fox Business
Allergan To Pay Map Pharma $60 Million To Co-Promote LevadexJanuary 31, 2011Health News - Fox Business
Midcap pharma stocks are attractive: Sudip BandyopadhyayDecember 07, 2010Pharmaceutical - Moreover
MAP Pharma Rallies On Migraine Drug UpdateSeptember 08, 2010Health News - Fox Business
MAP Pharma reports positive migraine drug resultsSeptember 08, 2010Health News - CNBC
AP Pharma narrows Q2 loss to $3.6MAugust 16, 2010Health News - BizJournals.com
MAP Pharma reports positive migraine drug dataJune 23, 2010Health News - CNBC
Share tip of the week: cheap pharma heavyweightJune 04, 2010Pharmaceutical - Moreover
AP Pharma CEO walks as board pursues manufacturing fixesMay 26, 2010FiercePharma Manufacturing
MAP Pharma reports migraine drug trial progressMay 11, 2010Health News - CNBC
FDA Denies Approval of AP Pharma Nausea DrugMarch 19, 2010Health News - Fox Business
MAP Pharma posts smaller 4Q loss as costs decreaseMarch 02, 2010Health News - CNBC



View all the latest news